Department of Organic Chemistry and Department of Molecular Pharmacology, CDRI, 114401 Khimki, Moscow Reg, Russia.
Bioorg Med Chem. 2013 Aug 1;21(15):4614-27. doi: 10.1016/j.bmc.2013.05.040. Epub 2013 Jun 1.
Substituted diphenyl sulfones (10a-n) were synthesised, and the structures were confirmed by NMR, LC-MS and X-ray crystallography. Their antagonistic activities towards 5-HT₆ receptor were assessed in a cell-based functional assay. Diphenyl sulfone 10a, in spite of being the smallest and simplest known sulfonyl-containing 5-HT₆R antagonist, showed a strong potency (Ki=1.6 μM). Its derivative with a methylamine substituent, 10g (N-methyl-2-(phenylsulfonyl)aniline), was ∼66-times as active as diphenyl sulfone (Ki=24.3 nM). Addition of a piperazinyl moiety in the para-position relative to the sulfonyl group in compound 10m (N-methyl-2-(phenylsulfonyl)-5-piperazin-1-ylaniline) led to a further 150-fold increase in potency (Ki=0.16 nM) to block the serotonin-induced response of HEK-293 cells that were stably transfected with the human recombinant 5-HT₆ receptor.
取代的二苯砜(10a-n)被合成,并通过 NMR、LC-MS 和 X 射线晶体学确证了其结构。在基于细胞的功能测定中评估了它们对 5-HT₆ 受体的拮抗活性。尽管二苯砜 10a 是已知的最小和最简单的含磺酰基的 5-HT₆R 拮抗剂,但它表现出很强的活性(Ki=1.6 μM)。其带有甲胺取代基的衍生物 10g(N-甲基-2-(苯磺酰基)苯胺)的活性约为二苯砜的 66 倍(Ki=24.3 nM)。在化合物 10m(N-甲基-2-(苯磺酰基)-5-哌嗪-1-基苯胺)中,在磺酰基的对位引入哌嗪基,使阻断稳定转染人重组 5-HT₆ 受体的 HEK-293 细胞中血清素诱导反应的活性进一步提高 150 倍(Ki=0.16 nM)。